Results 231 to 240 of about 27,901 (286)

Many but not all pathogen-associated molecular patterns aggravate neurogenic heterotopic ossification after spinal cord injury. [PDF]

J Biomed Sci
Samuel SG, Tseng HW, Rival B, Barbier V, Bisht K, Salga M, Mate SM, Fleming W, Genêt F, Banzet S, Lévesque JP, Girard D, Alexander KA.   +12 more
europepmc   +1 more source

CPK5-vermittelte PAMP-induzierte Signalweiterleitung und Effektor-abhängige Abwehrinitiierung

, 2017
Hake, Katharina 1987-
core   +1 more source

Brain endothelial cells orchestrate a neuroprotective antiviral state in the CNS in response to peripheral viral pattern sensing. [PDF]

Immunity
Lewy T, Sierra MA, Pourshadi N, Hoffmann HH, Dinnon KH, Gola A, Wang W, Chen HA, Quirk C, Zhang H, Doyle MP, Mason CE, Diehl GE, Hohl TM, Fuchs E, MacDonald MR, Wu Z, Crowe JE, Rice CM, Lercher A.   +19 more
europepmc   +1 more source

Suggestive characteristic change of CD123⁺dendritic cells in Kikuchi-Fujimoto Disease. [PDF]

J Clin Exp Hematop
Asano S, Mori K, Yamazaki K, Sato H, Naito H, Yamada R, Komohara Y.   +6 more
europepmc   +1 more source

Long-term follow-up of patients with pulmonary hypertension after catheter ablation of atrial fibrillation and atrial tachycardia. [PDF]

Front Cardiovasc Med
Dusik M, Havranek S, Fingrova Z, Jansa P, Ambroz D, Dytrych V, Skala T, Hutyra M, Precek J, Reichenbach A, Wichterle D.   +10 more
europepmc   +1 more source

Purification and characterization of PAMP-12 (PAMP[9-20]) in porcine adrenal medulla as a major endogenous biologically active peptide [PDF]

FEBS Letters, 1997
Proadrenomedullin N-terminal 20 peptide (PAMP-20) is a potent hypotensive peptide processed from the adrenomedullin (AM) precursor. We developed a specific radioimmunoassay which recognizes the C-terminal region of PAMP-20.
Johji Kato, Kazuo Kitamura, Y Ishiyama   +2 more
exaly   +2 more sources

Identification and hypotensive activity of proadrenomedullin N-terminal 20 peptide (PAMP) [PDF]

FEBS Letters, 1994
Proadrenomedullin N-terminal 20 peptide (PAMP) is a candidate for a novel biologically active peptide processed from an adrenomedullin precursor. Using a radioimmunoassay for human PAMP, major and minor immunoreactive PAMPs were purified from porcine ...
Kazuo Kitamura, Kenji Kangawa, Y Ichiki   +2 more
exaly   +2 more sources

Proadrenomedullin NH2-terminal 20 peptide (PAMP) and adrenomedullin bind to teratocarcinoma cells☆ [PDF]

Peptides, 2000
Proadrenomedullin NH(2-)terminal 20 peptide (PAMP) and adrenomedullin (ADM) bind to teratocarcinoma cells. The effects of PAMP and ADM on teratocarcinoma cells were investigated.
Terry Moody, Luis M Montuenga, F Cuttitta   +2 more
exaly   +1 more source

Proadrenomedullin N-terminal 20 peptide (PAMP) elevates blood glucose levels via bombesin receptor in mice [PDF]

FEBS Letters, 2000
We found a potent hyperglycemic effect of proadrenomedullin N-terminal 20 peptide (PAMP) after intra-third cerebroventricular administration at a dose of 10 nmol in fasted mice.
Kousaku Ohinata, E Wada, A Inui
exaly   +2 more sources